Health News Releases

  • Today February 18
October 04, 2016 13:50
QuintilesIMS: Merger Creates a Leading Global Integrated Information and Technology-Enabled Healthcare Service Provider
Quintiles IMS Holdings, Inc. (NYSE:Q) today announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdi
October 04, 2016 11:45
Samsung Bioepis' Marketing Authorization Application for SB3 Trastuzumab Biosimilar Candidate Accepted for Review by the European Medicines Agency
Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB3, a biosimilar candidate refer
September 30, 2016 09:45
Boehringer Ingelheim and Sarah Cannon Research Institute launch strategic collaboration to develop novel immune-oncology therapies
Boehringer Ingelheim and Sarah Cannon Research Institute, the research arm of Sarah Cannon, the global cancer institute of HCA, announced today a new strategic collaboration. This partnership brings t
September 29, 2016 11:50
Boehringer Ingelheim Boosts Immune-Oncology Pipeline Through Collaboration with ViraTherapeutics
Boehringer Ingelheim and ViraTherapeutics today announced a long term collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutic’s lead cand
September 27, 2016 13:35
Herbalife Nutrition and Special Olympics Announce $1 Million Fitness Collaboration
Herbalife (NYSE: HLF), a global nutrition company, today announced a $1 million collaboration with Special Olympics to support the organization’s fitness programming around the world, focusing on incr
September 23, 2016 19:30
Alexion Employees Volunteer Together in Company’s First Global Day of Service
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that more than 1,500 employees around the world are volunteering in their respective communities as part of the Company’s first Global Day o
September 22, 2016 13:40
SAB Biotherapeutics' Immunotherapy Proposal among Top Platform Technology Solutions in WHO Report
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company, announced today that its DiversitAb human antibody production platform, leveraging transchromosomic cattle (Tc Bovine
September 21, 2016 16:00
Smith & Nephew Reinforces Strong Educational Commitment to Advanced Wound Management at World Union of Wound Healing Societies Meeting (WUWHS)
Smith & Nephew (LSE:SN) (NYSE:SNN), the global medical technology business, highlights three scientific symposia at World Union of Wound Health Societies (WUWHS) on 25-29 September 2016 in Florence, I
September 21, 2016 14:00
Takeda and Zydus Cadila partner to address the global threat of Chikungunya
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcon
September 21, 2016 13:50
New survey reveals 9 out of 10 patients with IPF were happy with how their doctor told them about their IPF diagnosis
A diagnosis of IPF is news that few patients want to hear from their physician, but the reality is that approximately 3 million people worldwide are living with idiopathic pulmonary fibrosis (IPF). It
September 21, 2016 01:00
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
W. L. Gore & Associates, Inc. (Gore) today announced positive results from a prospective, multicenter Investigational Device Exemption (IDE) Clinical Study of the GORE® VIABAHN® Endoprosthesis with He
September 20, 2016 18:45
First Implant Completed in Pivotal Study of GORE® TAG® Thoracic Branch Endoprosthesis
W. L. Gore & Associates, Inc. (Gore) today announced the first implant of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) in the pivotal study. The patient was enrolled by Himanshu Patel, MD, sect
September 20, 2016 10:55
Biopharmaceutical Industry Calls the Recommendations of UN High Level Panel on Access to Medicines a Missed Opportunity to Genuinely Address Patients’ Needs
The biopharmaceutical industry believes the UN High Level Panel on Access to Medicines (HLP) lent an unprecedented opportunity to address critical issues affecting the ability of millions of people in
September 19, 2016 10:25
Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with Relapsing Multiple Sclerosis Presented at 32nd ECTRIMS
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced results from the 96-week blinded extension period (for a total of up to 120 weeks of exposur
September 19, 2016 10:15
Glyxambi® (empagliflozin/linagliptin) approval recommended by CHMP for adults with type 2 diabetes in the European Union
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) today recommended the approval of Glyxambi® (empagliflozin/linagliptin) for use in adults with type 2 d
September 19, 2016 10:10
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLARO™ (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recom
September 18, 2016 18:00
New LCP Monofilament Allows for MRI Guided Vascular Intervention
Magnetic resonance imaging (MRI) uses a strong magnetic field to image the body and is known as the gold standard in diagnostic imaging. This non-invasive imaging technique can be used to diagnose sev
September 13, 2016 18:30
Macrogen Launches ‘Easybox’, a Premium Temperature-Controlled Package
The precision medicine biotechnology enterprise Macrogen (CEO Hyeon-yong Jeong, www.macrogen.com) (KOSDAQ:038290) announced today its new premium temperature-controlled packaging named ‘EasyBox’ for c
September 13, 2016 11:40
Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL)
RFL is the largest grassroots fundraiser in the world and currently brings together cancer communities in more than 26 countries. Through this expansion, RFL expects to recruit and train new partners
September 13, 2016 11:25
Samsung Bioepis' SB4 (BRENZYS™) Becomes First Etanercept Biosimilar to Receive Regulatory Approval in Canada
Samsung Bioepis Co., Ltd. today announced that BRENZYS™ - a biosimilar referencing Enbrel® (etanercept), also known as SB4 - received regulatory approval in Canada for the treatment of rheumatoid arth
September 12, 2016 13:50
Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
Boehringer Ingelheim today announced that the European Commission (EC) and U.S. Food and Drug Administration (FDA) have granted Orphan Drug Designation to nintedanib for the treatment of systemic scle
September 09, 2016 15:45
Patient Safety Movement Foundation & Global Sepsis Alliance Join Forces to Reduce Preventable Deaths from Sepsis
The Patient Safety Movement Foundation is happy to announce its sponsorship and participation in the 1st World Sepsis Congress on September 8-9, 2016, convened by the Global Sepsis Alliance. Featured
September 08, 2016 15:50
New analysis showed dose adjustment of Giotrif® (afatinib) improved tolerability without an apparent impact on efficacy in patients with EGFR mutation-positive non-small cell lung cancer
Results from a new post-hoc analysis of two large Phase III trials (LUX-Lung 3 and LUX-Lung 6) assessing the impact of dose adjustments for Giotrif® (afatinib*) in patients with advanced non-small cel
September 08, 2016 14:45
GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance
W. L. Gore & Associates, Inc. (Gore) is celebrating the 20th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft for the treatment of complex periphera
September 08, 2016 11:00
New long-term data demonstrates continued safety and beneficial effect of OFEV® (nintedanib) for patients with IPF
Boehringer Ingelheim presented eight IPF-related abstracts at the European Respiratory Society (ERS) International Congress 2016, including new interim data from the INPULSIS®-ON extension trial asses
25 per page50 per page75 per page100 per page